ORPEA: Information on the Remuneration of Mr Philippe Charrier, Chairman and Chief Executive Officer
On February 23, 2022, ORPEA's Board of Directors approved the remuneration of CEO Philippe Charrier, setting a fixed annual salary of 760,000 euros for the period from January 30, 2022, to December 31, 2022. This amount remains unchanged from the previous year. The decision regarding annual variable compensation and performance share grants for 2022 has been postponed. ORPEA operates a network of 1,156 facilities with 116,514 beds across 23 countries, emphasizing its strong position in the long-term care sector.
- CEO Philippe Charrier's remuneration remains stable at 760,000 euros.
- ORPEA has a substantial infrastructure with 1,156 facilities and 116,514 beds globally.
- Postponement of decisions on annual variable compensation and performance share grants may signal uncertainties.
PUTEAUX,
The Board of Directors, during its meeting on
Fixed annual remuneration
Mr.
Annual variable compensation and performance share grants for 2022
The Board of Directors has decided to postpone any decision to be taken in accordance with the remuneration policy concerning a possible annual variable compensation or concerning the granting of performance shares for 2022.
Remuneration for directorship
Mr.
About
Founded in 1989,
- France Benelux: 586 facilities / 49,207 beds (5,672 of which are under construction)
-
-
-
- Other countries: 2 facilities / 525 beds (385 of which are under construction)
View source version on businesswire.com: https://www.businesswire.com/news/home/20220225005252/en/
Investor Relations
EVP Communication and Investor Relations
s.grobet@orpea.net
Investor Relations Director
b.lesieur@orpea.net
Investor Relations
NewCap
Dusan Oresansky
Tel.: +33 (0)1 44 71 94 94
orpea@newcap.eu
Media Relations
Image 7
Tel.: +33 (0)6 89 87 61 37
lheilbronn@image7.fr
Tel.: +33 (0)6 78 37 27 60
clebarbier@image7.fr
Source:
FAQ
What is the fixed remuneration for ORPEA's CEO for 2022?
When did ORPEA's Board of Directors meet to discuss remuneration?
How many facilities does ORPEA operate worldwide?
What decision regarding compensation was postponed by ORPEA?